Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis

Summary

The objective of the proposed study is to determine whether BL-7040 demonstrates clinical efficacy in patients with inflammatory bowel disease (IBD).

Timeline

Start

2012-03

Primary completion

2013-05

Completion

2013-05

Outcome

Met primary endpoint

release “BL-7040 met the primary efficacy endpoint of the study” biolinerx.com ↗

Drugs

Indications